Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-24-012414

Head of Development sold 93 shares at $213.09 ($19,817)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Singhal Priya Head of Development 2024-04-02 Sale 10b5-1 −93 $213.09 $19,817 4,886.48 D: show line 1 in the form
Open-market sales · 93 sh · avg $213.09 · $19,817
Loading xslF345X05/form4.xml…